DO VACCINIA VIRUS-ENCODED SERPINS INHIBIT ANTIGEN PRESENTATION TO CLASS I-RESTRICTED CTL

DO VACCINIA VIRUS-ENCODED SERPINS INHIBIT ANTIGEN PRESENTATION TO CLASS I-RESTRICTED CTL

Bibliographic Details
Main Authors:	Blake, N, Kettle, S, Gould, K, Bastin, J, Townsend, A, Smith, G
Format:	Journal article
Published:	1993

Similar Items

Vaccinia virus serpins B13R and B22R do not inhibit antigen presentation to class I-restricted cytotoxic T lymphocytes.
by: Blake, N, et al.
Published: (1995)

Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen.
by: Townsend, A, et al.
Published: (1988)

A 15 amino acid fragment of influenza nucleoprotein synthesized in the cytoplasm is presented to class I-restricted cytotoxic T lymphocytes.
by: Gould, K, et al.
Published: (1989)

Induction of potent antitumor CTL responses by recombinant vaccinia encoding a melan-A peptide analogue.
by: Valmori, D, et al.
Published: (2000)

Antigen recognition by class I-restricted T lymphocytes.
by: Townsend, A, et al.
Published: (1989)

MHC CLASS-I EXPRESSION IN TRANSPLANTATION TOLERANCE AND PEPTIDE PRESENTATION TO CTL - A MUTANT-CELL THAT FAILS TO PRESENT INTERNALLY DERIVED H-2 RESTRICTED ANTIGENS BUT REMAINS SENSITIVE TO ALLO H-2 SPECIFIC RESPONSES
by: Ohlen, C, et al.
Published: (1989)

Antigen presentation and the association of class-I molecules.
by: Elliott, T, et al.
Published: (1991)

Processing of major histocompatibility class I-restricted antigens in the endoplasmic reticulum.
by: Elliott, T, et al.
Published: (1995)

Characterisation of serpin polymers in vitro and in vivo.
by: Belorgey, D, et al.
Published: (2011)

Immunodominance of poxviral-specific CTL in a human trial of recombinant-modified vaccinia Ankara.
by: Smith, C, et al.
Published: (2005)

Mouse H-2(k)-restricted cytotoxic T cells recognize antigenic determinants in both the HA1 and HA2 subunits of the influenza A/PR/8/34 hemagglutinin
by: Gould, K, et al.
Published: (1987)

The T cell receptor from an influenza-A specific murine CTL clone.
by: Palmer, MS, et al.
Published: (1989)

Dendritic cell/tumour fusions are more efficient at eliciting MHC class I-restricted Ag-specific CTL responses when compared to antigen-pulsed dendritic cells
by: Galea-Lauri, J, et al.
Published: (2001)

A defect in the presentation of intracellular viral antigens is restored by interferon-gamma in cell lines with impaired major histocompatibility complex class I assembly.
by: Sibille, C, et al.
Published: (1992)

Loss of major histocompatibility complex-encoded transporter associated with antigen presentation (TAP) in colorectal cancer.
by: Kaklamanis, L, et al.
Published: (1994)

Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrence.
by: Smith, C, et al.
Published: (2005)

Use of synthetic peptides of influenza nucleoprotein to define epitopes recognized by class I-restricted cytotoxic T lymphocytes.
by: Bastin, J, et al.
Published: (1987)

Characterization of an HLA-C-restricted CTL response in chronic HIV infection.
by: Makadzange, A, et al.
Published: (2010)

The transporters associated with antigen presentation.
by: Townsend, A, et al.
Published: (1993)

Enhanced immunogenicity of CTL antigens through mutation of the CD8 binding MHC class I invariant region.
by: Wooldridge, L, et al.
Published: (2007)

Presentation of IgG2a antigens to class II-restricted T cells by stably transfected B lymphoma cells.
by: Bikoff, E, et al.
Published: (1989)

Antigen processing shapes HIV-specific CTL-response hierarchies
by: Tenzer, S, et al.
Published: (2008)

The nested open reading frame in the Epstein-Barr virus nuclear antigen-1 mRNA encodes a protein capable of inhibiting antigen presentation in cis.
by: Ossevoort, M, et al.
Published: (2007)

Antigen processing. A new presentation pathway?
by: Townsend, A
Published: (1992)

Antigen presentation. Naturally processed peptides.
by: Elliott, T, et al.
Published: (1990)

A serpin regulates dorsal-ventral axis formation in the Drosophila embryo.
by: Ligoxygakis, P, et al.
Published: (2003)

The efficiency of antigen recognition by CTL is determined by the frequency of serial TCR engagement.
by: Hudrisier, D, et al.
Published: (1998)

Motif inference reveals optimal CTL epitopes presented by HLA class I alleles highly prevalent in southern Africa.
by: Honeyborne, I, et al.
Published: (2006)

Antigen processing defects in cervical carcinomas limit the presentation of a CTL epitope from human papillomavirus 16 E6.
by: Evans, M, et al.
Published: (2001)

Characterisation of antigenic MHC Class I-restricted T cell epitopes in the glycoprotein of Ebolavirus
by: Powlson, J, et al.
Published: (2019)

NO ADDITIONAL ROLE FOR THE MHC CLASS-II ENCODED COMPONENTS OF THE HLA CLASS-I PATHWAY OF ANTIGEN PRESENTATION (LMP2, TAP1-AND-2) IN THE ETIOLOGY OF ANKYLOSING-SPONDYLITIS (AS)
by: Pile, K, et al.
Published: (1993)

Folding of an MHC class II-restricted tumor antigen controls its antigenicity via MHC-guided processing.
by: Mimura, Y, et al.
Published: (2007)

A serpin mutant links Toll activation to melanization in the host defence of Drosophila.
by: Ligoxygakis, P, et al.
Published: (2002)

Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer.
by: Spies, T, et al.
Published: (1992)

Analysis of the MHC class II encoded components of the HLA class I antigen processing pathway in ankylosing spondylitis.
by: Burney, R, et al.
Published: (1994)

Exogenous peptides delivered by ricin require processing by signal peptidase for transporter associated with antigen processing-independent MHC class I-restricted presentation.
by: Smith, D, et al.
Published: (2002)

Class II MHC Self-Antigen Presentation in Human B and T Lymphocytes
by: Costantino, Cristina Maria, et al.
Published: (2012)

Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice.
by: Hanke, T, et al.
Published: (1998)

Mucosal immunization with PLGA-microencapsulated DNA primes a SIV-specific CTL response revealed by boosting with cognate recombinant modified vaccinia virus Ankara.
by: Sharpe, S, et al.
Published: (2003)

Generation of an immunodominant CTL epitope is affected by proteasome subunit composition and stability of the antigenic protein.
by: Gileadi, U, et al.
Published: (1999)